drugset / Trial / NCT01068613

Safety and Efficacy of Multiple Doses of QAX028 in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT01068613

Phase 2 Completed 62 enrolled Novartis Pharmaceuticals
RandomizedCrossoverTriple-blindTreatment

Summary

This study will assess the bronchodilator effects of multiple doses of QAX028 at two different dose levels when compared to tiotropium and placebo in a COPD population.

Timeline

Start
2010-01
Primary completion
2010-08
Completion
2010-08

Drugs

EvaluationDrugModalityDoseRoute
Subject QAX028 Unknown 20 ug Inhaled
Subject QAX028 Unknown 60 ug Inhaled
Comparator Tiotropium Other / unclassified Inhaled